Lefancaps®, a professional manufacturer and service provider of hard capsules, is now exhibiting at the AAPS 2022 PharmSci 360 – American Association of Pharmaceutical Scientists (aaps.org) convention in Boston.


AAPS Pharm Sci 360 is an exhibition which showcases exhibiting partners’products and services,  and provides a platform for exchanging pharmaceutical scientific knowledge and scientific programs.

At this exhibition, Lefancaps® will talk about its new arrivals: preclinical capsules, double-blind capsules and all-color capsules, so as to provide preclinical and clinical solutions, speed to clinic.

1. PRECLINICAL CAPSULES

Preclinical capsules are tiny capsule shells that can be used in animal testing for preclinical studies. Lefancaps® can offer different shell materials upon demand, such as gelatin,HPMC and etc. If your dosage forms are sensitive to moisture, likely to have cross-linking reactions with gelatin,or have a religious or vegetarian demand, HPMC capsules can be selected.

Lefancaps® can provide preclinical capsules with different disintegration properties, such as gastric-soluble,enteric-soluble and delay-released capsules.

The formulation can be customized upon user’s demand.

2. DOUBLE-BLIND CAPSULES

Double-blind capsules are specifically designed for double-blind clinical trials.

Lefancaps® sincerely invites you to attend AAPS Pharm Sci 360 and visit our booth for new products.

Lefancaps® offers 2 types of double-blind capsules, double-blind gelatin capsules and double-blind HPMC capsules (w/o gelling agent).The disintegration time of these two capsules will not affect property of internal solid dosage forms. If your dosage forms are sensitive to moisture, likely to have cross-linking reactions with gelatin, or have a religious or vegetarian demand, double-blind HPMC capsules(w/o gelling agent)can be selected.

Dual locking rings design with extended cap length. More overlapping between the cap and the body compared with standard capsules. Double layer of opaque material assures more opacity of the encapsulated dosage forms and difficulty to open the capsules. The overall design of clinical capsules is shorter than that of standard capsules and easier for patients to swallow. The formulation design of opaque material can be customized according to the regulatory requirements of intended markets. Covering or disposing logos for internal dosage forms is not required with the use of clinical capsules.

3. ALL-COLOR CAPSULES

Lefancaps®all-color capsules are available to support stability and compatibility studies before deciding on the final color for the capsules at drug development phase. An all colorants capsule involves a selection of colorants into a capsule shell which generates maximum data on the type and additive amounts of colorants through stability and compatibility studies, makes the final color decision cuts development time as well as streamline the development progress.

Lefancaps® sincerely invites you to attend AAPS Pharm Sci 360 and have a look at our new arrivals.